DB
KIDS icon

Dmitry Balyasny’s OrthoPediatrics KIDS Stock Holding History

Dmitry Balyasny’s Portfolio KIDS Stock Details KIDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,006
Closed -$238K – 3268
2026
Q1 		$238K Buy
15,006
+109
+0.7% +$1.9K ﹤0.01% 2641
2025
Q4 		$265K Buy
+14,897
New +$261K ﹤0.01% 2780

Other funds holding KIDS

Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Dmitry Balyasny's KIDS Position: Q2 2026 in Review

Dmitry Balyasny sold out of OrthoPediatrics (KIDS) in Q2 2026, closing a stake of 15,006 shares — an estimated $238K sold.

Dmitry Balyasny first reported a position in KIDS in Q4 2025 and held it in 2 quarters. The position peaked at $265K in Q4 2025. 119 funds tracked by Wall St. Rank hold KIDS as of Q2 2026.

  • Dmitry Balyasny reported no remaining OrthoPediatrics position as of Q2 2026 after selling out during the quarter.
  • Dmitry Balyasny sold 15,006 OrthoPediatrics shares in Q2 2026, an estimated $238K.
  • Dmitry Balyasny first reported a position in OrthoPediatrics in Q4 2025 and held it in 2 quarters.
  • Dmitry Balyasny's OrthoPediatrics position peaked at $265K in Q4 2025.
  • 119 funds tracked by Wall St. Rank held OrthoPediatrics as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.